Alaunos Therapeutics(us:TCRT)
1.96
-2.97%
Updated on 2024-12-22
Open:2.02
Close:1.96
High:2.04
Low:1.95
Pre Close:2.02
Volume:9701.00
Amount:19231.30
Turnover:0.61%
Shares:1.60M
MarketCap:3.14M
About Alaunos Therapeutics Company
ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of immuno-oncology platforms that leverage cell- and gene-based therapies to treat patients with cancer. Its pipeline includes Sleeping Beauty TCR-T Targeting neoantigens; Ad-RTS-hlL-12 + veledimex; and Sleeping Beauty CAR-T. The company was founded on September 9, 2003 and is headquartered in Boston, MA.
Company Name: Alaunos Therapeutics
Company Address: Navy Yard Plaza,1 First Avenue,Parris Building 34, 3rd floor
Employees: 1
Fiscar Year: 12-31
IPO Date: 2006-09-22
Website: http://www.ziopharm.com
CIK: 1107421
View all SEC Filings
About
ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of immuno-oncology platforms that leverage cell- and gene-based therapies to treat patients with cancer. Its pipeline includes Sleeping Beauty TCR-T Targeting neoantigens; Ad-RTS-hlL-12 + veledimex; and Sleeping Beauty CAR-T. The company was founded on September 9, 2003 and is headquartered in Boston, MA.
Address:Navy Yard Plaza,1 First Avenue,Parris Building 34, 3rd floor
Website:http://www.ziopharm.com
Market Movers